ad

MANIPAL HEALTH ENTERPRI L (MANIPALHOS) Share Price Hits Fresh 52-Week High

17 Aug 202612:19 pm

MANIPAL HEALTH ENTERPRI L (MANIPALHOS) Share Price Hits Fresh 52-Week High

MANIPAL HEALTH ENTERPRI L Share Price rose 2.21% to Rs 723 and touched a fresh 52-week high of Rs 729. The stock's market capitalisation stands at Rs 93,043.21 crore.

MANIPAL HEALTH ENTERPRI L Share Price is at Rs 723 today, up 2.21% or Rs 15.65 from the previous close of Rs 707.35, after touching a fresh 52-week high of Rs 729. The move puts the company’s market capitalisation at Rs 93,043.21 crore and places it firmly among stocks in news in the Indian stock market session.

For investors searching MANIPAL HEALTH ENTERPRI L Share Price Today, the verified data shows a clear price event: the stock opened at Rs 711.55, moved within a day range of Rs 700.55 to Rs 729, and reached a new one-year high during the session. Turnover stood at Rs 7.3 crore with volume of 1,00,971 shares, pointing to active participation as the stock tested higher levels.

Why is it trending in MANIPAL HEALTH ENTERPRI L Stock News and share market today searches? The supplied data confirms the fresh 52-week high and a positive day move, but it does not establish a company-specific catalyst. That means the attention is being driven by verified price action, valuation context and sector comparison rather than an identified announcement in the data reviewed by Univest.

The financial context is also notable. MANIPAL HEALTH ENTERPRI L Share Price trades at a P/E ratio of 184.72 and a P/B ratio of 0.45, while ROE is -2.89 and ROCE is -0.26. Investors tracking Univest should watch whether the stock sustains this yearly high zone, how its valuation compares with healthcare benchmarks, and how peer metrics frame the current move.

MANIPAL HEALTH ENTERPRI L Share Price Today: Price Action Analysis

Metric Value
Current Price Rs 723
Previous Close Rs 707.35
Today's Change +Rs 15.65 (+2.21%)
Day Open Rs 711.55
Fresh 52-Week High Rs 729
Day Low Rs 700.55
Current Volume 1,00,971
Turnover Rs 7.3 crore
Market Capitalisation Rs 93,043.21 crore

MANIPAL HEALTH ENTERPRI L (MANIPALHOS) traded at Rs 723. versus the previous close of Rs 707.35, a rise of 2.21%. The stock opened at Rs 711.55, reached Rs 729, touched Rs 700.55. Reported volume was 1,00,971.

MANIPAL HEALTH ENTERPRI L Share Price Today reflects a strong session in absolute price terms, with the stock rising from Rs 707.35 to Rs 723 and touching a fresh 52-week peak of Rs 729. The intraday range, turnover and traded volume show that the move was accompanied by meaningful market activity rather than a static quote change.

At the time of this MANIPAL HEALTH ENTERPRI L Share Price Update, the stock was trading Rs 15.65 above its previous close, translating into a 2.21% gain for the day. The session began at Rs 711.55, which was already above the previous close, and the stock then moved to an intraday low of Rs 700.55 before rallying to Rs 729. That range suggests two-way price action early in the day, followed by enough buying support to push the stock to a new 52-week high.

The difference between the current price of Rs 723 and the day’s high of Rs 729 shows that the stock remained close to its strongest intraday level even after some cooling from the peak. In stock price terms, that keeps MANIPAL HEALTH ENTERPRI L Share Price firmly in focus for traders looking at market movers, 52 Week High Stocks and daily price action.

Turnover came in at Rs 7.3 crore, while traded volume stood at 1,00,971 shares. For MANIPAL HEALTH ENTERPRI L Share News watchers, that combination matters because it confirms that the move was backed by actual exchange activity. The data therefore establishes what happened today: a positive session, a fresh yearly high and sustained trading interest. The next question is whether the fundamentals offer support for the attention MANIPAL HEALTH ENTERPRI L Share Price is getting.

MANIPAL HEALTH ENTERPRI L (MANIPALHOS) Fundamental Analysis

Metric Value
Market Capitalisation Rs 93,043.21 crore
P/E Ratio 184.72x
P/B Ratio 0.45x
ROE -2.89%
ROCE -0.26%

MANIPAL HEALTH ENTERPRI L was valued at a P/E ratio of 184.72x, a P/B ratio of 0.45x. These multiples provide valuation context, but they should not be labelled expensive or inexpensive without a comparable peer or sector benchmark.

Profitability and capital efficiency were represented by ROE of -2.89% and ROCE of -0.26%. ROE relates profit to shareholder equity, while ROCE measures returns generated on the capital employed in the business.

Sector and Industry Context

Metric Value
Sector Healthcare
Benchmark Scope same sector
Company P/E Ratio 184.72x
Benchmark Median P/E 21.1x
Benchmark Average P/E 49.38x
Benchmark P/E Range 0x to 1,603.4x
Company P/B Ratio 0.45x
Benchmark Median P/B 1.9x
Company ROE -2.89%
Benchmark Median ROE 10.71%
Company ROCE -0.26%
Benchmark Median ROCE 13.15%
Company Market Capitalisation Rs 93,043.21 crore
Benchmark Median Market Cap Rs 135.27 crore

MANIPAL HEALTH ENTERPRI L (MANIPALHOS) is classified under sector: Healthcare.

MANIPAL HEALTH ENTERPRI L (MANIPALHOS) has a P/E ratio of 184.72x, which is above the benchmark median of 21.1x, a difference of +775.45%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.

MANIPAL HEALTH ENTERPRI L (MANIPALHOS) has a ROE of -2.89%, which is below the benchmark median of 10.71%, a difference of -126.98%. MANIPAL HEALTH ENTERPRI L (MANIPALHOS) has a ROCE of -0.26%, which is below the benchmark median of 13.15%, a difference of -101.98%.

Track stocks reaching yearly peaks through the Univest 52-week-high screener. The peer table below provides the company-level comparison.

Peer Comparison

Company Symbol Market Cap (Cr) P/E P/B ROE (%) ROCE (%)
Dishman Carbogen Amcis Ltd. DCAL 2,985.15 184.72 0.45 -2.89 -0.26
Beta Drugs Ltd. BETA 2,827.67 68.16 6.74 18.65 22.17
Ind-Swift Laboratories Ltd. INDSWFTLAB 2,645.37 46.15 1.77 -0.78 8.31
Dr Agarwals Eye Hospital Ltd. DRAGARWQ 2,612.26 34.27 7.07 -2.6 16.92
Fredun Pharmaceuticals Ltd. FREDUN 2,559.68 58.41 8.73 11.42 13.15

MANIPAL HEALTH ENTERPRI L (MANIPALHOS) has a P/E ratio of 184.72x compared with the displayed peer median of 58.41x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of -2.89% compares with a peer median of -0.78% across the companies shown in the table. ROCE stood at -0.26% versus the displayed peer median of 13.15%, providing a capital-efficiency comparison. MANIPAL HEALTH ENTERPRI L (MANIPALHOS) has a market capitalisation of Rs 93,043.21 crore. Among the 5 peers shown, 0 have a larger market capitalisation.

Why Investors Are Watching MANIPAL HEALTH ENTERPRI L

Investors are watching MANIPAL HEALTH ENTERPRI L Share Price because the stock has printed a fresh 52-week high while also showing a valuation and profitability profile that is not straightforward. The move is attracting attention from both momentum-focused market participants and investors comparing healthcare valuations across the sector.

  • Fresh price event: The stock rose 2.21% to Rs 723 and touched a new 52-week high of Rs 729.
  • Active session: Turnover of Rs 7.3 crore and volume of 1,00,971 shares confirm meaningful trading activity.
  • Large size: Market capitalisation stands at Rs 93,043.21 crore, making the stock materially larger than the supplied sector benchmark averages.
  • Valuation contrast: P/E is 184.72 versus sector median 21.1 and average 49.38, while P/B is 0.45 versus sector median 1.9 and average 2.3.
  • Profitability watch: ROE is -2.89 and ROCE is -0.26, both below the sector median and average.
  • Peer context: Compared with the supplied peers, the stock combines far greater market scale with weaker return ratios and an elevated earnings multiple.

For Univest users, the key monitor now is whether MANIPAL HEALTH ENTERPRI L Share Price can hold near its yearly high while investors continue to weigh price strength against the supplied fundamental profile.

About MANIPAL HEALTH ENTERPRI L

MANIPAL HEALTH ENTERPRI L, traded under the symbol MANIPALHOS, is classified within the Healthcare sector in the supplied market dataset. In today’s market update, the stock has drawn attention because it entered the list of 52 Week High Stocks, with MANIPAL HEALTH ENTERPRI L Share Price touching Rs 729 during the session.

Based on the verified fields available for this article, the company is being evaluated here through its exchange-traded price action, market capitalisation and sector positioning rather than a broader operational profile. For readers tracking MANIPAL HEALTH ENTERPRI L NSE and MANIPAL HEALTH ENTERPRI L BSE style search intent, the most relevant current context is that the stock belongs to the healthcare space and is now being watched for its relative valuation, profitability ratios and peer standing within that sector.

As Univest continues to track market trends and stock updates, MANIPAL HEALTH ENTERPRI L remains a name to follow for its combination of scale, fresh one-year-high status and unusual mix of high P/E, low P/B and negative return ratios in the supplied data.

Track MANIPAL HEALTH ENTERPRI L Share Price on Univest

Use MANIPAL HEALTH ENTERPRI L (MANIPALHOS) live share-price page, Univest 52-week-high screener, Univest market blogs to review live stock data, yearly-high lists and related market analysis.

Readers can track MANIPAL HEALTH ENTERPRI L Share Price on Univest for live share price updates, 52-week levels, stock performance, valuation ratios, sector comparison and broader market insights. Univest helps investors follow MANIPAL HEALTH ENTERPRI L Share Price Today in one place, including market cap, P/E, P/B, ROE, ROCE and peer context.

For users searching MANIPAL HEALTH ENTERPRI L Share Price Live, MANIPAL HEALTH ENTERPRI L Latest News or MANIPAL HEALTH ENTERPRI L Company News, Univest provides a structured way to monitor price action alongside fundamental and sector data. After a fresh 52-week high, that combination becomes especially useful because it helps separate a verified market event from unsupported assumptions about why the stock is moving.

Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).

Frequently Asked Questions

What is the current MANIPAL HEALTH ENTERPRI L Share Price?

Ans. MANIPAL HEALTH ENTERPRI L Share Price was Rs 723 at the time of this update. The stock was up Rs 15.65, or 2.21%, from the previous close of Rs 707.35 after touching a fresh 52-week high.

What is the fresh 52-week high for MANIPAL HEALTH ENTERPRI L?

Ans. The stock touched a fresh 52-week high of Rs 729 during the session. It later traded at Rs 723, still close to the peak, which kept MANIPAL HEALTH ENTERPRI L Share Price firmly in focus for the day.

Why is MANIPAL HEALTH ENTERPRI L Share Price rising today?

Ans. The supplied data confirms that the stock rose 2.21% and reached a fresh one-year high of Rs 729. However, the verified dataset does not establish a company-specific catalyst behind today’s move in MANIPAL HEALTH ENTERPRI L Share Price.

What does today’s intraday range show for the stock?

Ans. The stock opened at Rs 711.55, fell to a day low of Rs 700.55 and then climbed to Rs 729. That range shows MANIPAL HEALTH ENTERPRI L Share Price absorbed early volatility before pushing to a yearly high.

How much market activity was seen in the stock today?

Ans. Trading activity included volume of 1,00,971 shares and turnover of Rs 7.3 crore. Those figures show that the move in MANIPAL HEALTH ENTERPRI L Share Price was backed by active participation during the session.

What is the market capitalisation of MANIPAL HEALTH ENTERPRI L?

Ans. The company’s market capitalisation is Rs 93,043.21 crore based on the supplied data. That makes MANIPAL HEALTH ENTERPRI L far larger than the healthcare sector benchmark median of Rs 135.27 crore and average of Rs 456.49 crore.

How is MANIPAL HEALTH ENTERPRI L valued on P/E and P/B?

Ans. MANIPAL HEALTH ENTERPRI L trades at a P/E ratio of 184.72 and a P/B ratio of 0.45. The P/E is above the healthcare sector median of 21.1, while the P/B is below the sector median of 1.9.

What do ROE and ROCE indicate for MANIPAL HEALTH ENTERPRI L?

Ans. The supplied figures show ROE at -2.89 and ROCE at -0.26. Both are below the healthcare sector medians of 10.71 and 13.15, indicating weaker profitability metrics than the broader benchmark set.

How does MANIPAL HEALTH ENTERPRI L compare with selected healthcare peers?

Ans. Compared with Beta Drugs, Ind-Swift Laboratories, Dr Agarwals Eye Hospital and Fredun Pharmaceuticals, MANIPAL HEALTH ENTERPRI L has a much larger market cap, a higher P/E than most peers, and weaker supplied return ratios.

Why are investors tracking MANIPAL HEALTH ENTERPRI L on Univest?

Ans. Investors are tracking MANIPAL HEALTH ENTERPRI L on Univest because the stock has hit a fresh 52-week high. Users can follow live share price, market cap, valuation ratios, peer comparison and sector context in one place.

Recent Articles

Note: This blog is for information purpose only. Investments and trading are subject to market risks, read all scheme related documents carefully.

Reviews

user-review-1
user-review-2
user-review-3
user-review-4
user-review-5
ad

Uniresearch Global Pvt Ltd
Research Analyst
SEBI Registration Number — INH000013776
Uniresearch is a subsidiary of Univest Communication Technologies Private Limited

Company Address: Registered Address: Ground Floor, Unitech Commercial Tower 2, Block B, Greenwood City, Unit 1-3, Sector 45, Gurugram, Haryana 122003

Write to us : support@univest.in, compliance@univest.in

Verify on SEBI registry →

RESEARCH ANALYST

Get SEBI Registered
advice on the stocks
trending today.

Get 3 FREE Trade Ideas

+91
for Startups Accelerator 2024

for Startups Accelerator 2024

Trusted by 1Cr Indians

Trusted by 1Cr Indians

Awarded No.1 by Economic Times

Awarded No.1 by Economic Times

GET THE APP

Join 1Cr users today.

SEBI Registered Analyst-backed Picks. Free Demat. One App

  • Free Demat account in under 5 minutes
  • Live market data — Nifty, Sensex, sector insights
  • SEBI Registered analyst-backed stock picks
Get it on Google PlayDownload on the App Store

Copyright 2026 Univest. All rights reserved.
Designed with ❤️ in India

arrow down